Kimera® Labs Responds to FDA Warning Letter
Category : Warning/Recalls 24 January 2024Kimera® Labs Inc., a privately held clinical stage biotechnology company, responded to a Warning Let...
Kimera® Labs Inc., a privately held clinical stage biotechnology company, responded to a Warning Let...
Inopak Ltd.'s drug manufacturing facility in Ringwood, New Jersey, underwent an FDA inspection from...
After pumping millions into its manufacturing capacity to keep up with COVID-related demand and bols...
Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative p...
The use of an anti-cold fixed drug combination has been prohibited by the Indian drugs regulator Cen...